Tango Therapeutics Cash Flow Statement (2020-2026) | TNGX

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-4.49M-19.59M-22.05M-25.21M-24.86M-29.05M-29.11M-28.01M-20.75M-22.26M-30.73M-37.91M-25.55M-29.17M-37.67M-39.88M-38.85M15.88M-38.75M-45.51M
Depreciation and Depletion (Quarter)
0.20M0.20M0.26M0.30M0.32M0.42M0.57M0.60M0.58M0.61M0.62M0.60M0.66M0.64M0.60M0.60M0.60M0.60M0.48M0.50M
Share-based Compensation (Quarter)
1.20M3.43M2.26M3.21M3.42M3.81M3.79M4.22M5.12M4.86M4.88M6.72M7.54M7.18M7.46M7.25M6.57M6.62M5.98M77.10M
Cash from Operations (Quarter)
-7.52M-21.49M-16.90M-29.66M-31.54M-19.61M-28.27M-34.91M-24.47M-31.14M-27.47M-37.86M-23.61M-33.39M-36.65M-41.70M-36.52M-30.95M-29.72M-44.36M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.89M-0.88M0.74M-2.36M-1.37M-1.20M-1.19M-0.86M-0.64M-0.72M-0.56M-0.77M-1.12M
Amortization of Deferred Charges (Quarter)
0.25M0.26M0.32M0.36M0.37M0.80M0.88M0.88M0.90M0.91M0.91M0.93M0.93M0.94M0.95M1.01M1.02M0.97M0.96M0.97M
Depreciation & Amortization (CF) (Quarter)
0.20M0.20M0.26M0.30M0.32M0.42M0.57M0.60M0.58M0.61M0.62M0.60M0.66M0.64M0.60M0.60M0.60M0.60M0.48M0.50M
Change in Working Capital
Change in Receivables (Quarter)
-2.00M
Change in Account Payables (Quarter)
0.19M-1.88M0.36M-0.36M-2.00M4.49M-1.04M1.55M-1.21M-1.96M-0.09M1.04M-2.77M3.05M-2.51M1.63M-0.88M-0.34M-1.23M1.78M
Change in Accured Expenses (Quarter)
0.56M3.87M0.04M-0.16M4.42M1.59M1.78M-6.70M2.46M-1.78M4.00M-1.61M3.02M-1.77M1.49M-6.12M1.14M1.60M4.49M-8.69M
Change in Taxes (Quarter)
-0.01M
Other Working Capital Changes (Quarter)
-9.17M1.21M11.48M3.69M-11.22M8.84M-18.17M2.78M-4.24M-0.39M4.08M-0.36M-2.14M1.49M0.64M-0.78M-0.81M-60.79M2.30M
Investing Activities
Capital Expenditures (Quarter)
-0.18M0.43M-0.26M0.50M-0.51M6.66M1.04M0.62M0.66M0.02M-1.26M-0.04M0.55M-0.55M0.79M0.05M0.26M-0.08M0.08M-0.01M
Change in Acquisitions & Divestments (Quarter)
59.83M30.42M59.87M44.41M53.23M62.96M81.99M84.70M84.13M99.59M85.10M109.25M61.63M72.15M84.73M77.81M41.34M65.97M39.52M64.05M
Cash from Investing Activities (Quarter)
-6.62M-152.21M-45.21M-11.72M35.49M15.23M-12.61M31.55M32.69M-56.66M33.85M-11.20M12.70M32.57M52.06M30.60M16.78M47.48M-135.72M9.63M
Financing Activities
Other financing activities (Quarter)
0.10M0.27M0.07M0.00M17.61M
Cash from Financing Activities (Quarter)
-0.75M327.78M-0.12M0.26M0.72M0.11M0.53M0.07M0.59M80.28M1.47M42.98M1.31M2.40M0.97M0.00M0.58M2.54M219.38M79.85M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
41.72M
Additional items
Change in Cash (Quarter)
-14.89M154.07M-62.23M-41.12M4.67M-4.27M-40.34M-3.28M8.80M-7.52M7.85M-6.08M-9.60M1.58M16.38M-11.10M-19.16M19.07M53.94M45.12M
Free Cash Flow (Quarter)
-7.34M-21.92M-16.64M-30.16M-31.03M-26.27M-29.31M-35.53M-25.14M-31.15M-26.20M-37.82M-24.16M-32.84M-37.44M-41.75M-36.77M-30.87M-29.80M-44.35M
Net Cash Flow (Quarter)
-14.89M154.07M-62.23M-41.12M4.67M-4.27M-40.34M-3.28M8.80M-7.52M7.85M-6.08M-9.60M1.58M16.38M-11.10M-19.16M19.07M53.94M45.12M